Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Unternehmens-codeTEM
Name des UnternehmensTempus AI Inc
IPO-datumJun 14, 2024
Gegründet am2015
CEOMr. Eric P. Lefkofsky
Anzahl der mitarbeiter2400
WertpapierartOrdinary Share
GeschäftsjahresendeJun 14
Addresse600 West Chicago Avenue
StadtCHICAGO
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl60654
Telefon18009765448
Websitehttps://www.tempus.com/
Unternehmens-codeTEM
IPO-datumJun 14, 2024
Gegründet am2015
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten